Search research articles
Contact Us
Filters
Showing results (141-150 of 160) with videos related to
Page
of 16
Sort By:
Molecular and Cellular Biochemistry
|
February 9, 1994
Human AT1 receptor is a single copy gene: characterization in a stable cell line
N Aiyar, E Baker, H L Wu, et al.
British Journal of Pharmacology
|
April 11, 2007
GW3965, a synthetic liver X receptor (LXR) agonist, reduces angiotensin II-mediated pressor responses in Sprague-Dawley rats
C E Leik, N L Carson, J K Hennan, et al.
The American Journal of Pathology
|
July 6, 2000
Endothelin receptor subtype distribution predisposes coronary arteries to damage
C S Louden, P Nambi, M A Pullen, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 8, 1998
Nonpeptide endothelin receptor antagonists. XI. Pharmacological characterization of SB 234551, a high-affinity and selective nonpeptide ETA receptor antagonist
E H Ohlstein, P Nambi, D W Hay, et al.
The American Journal of Physiology
|
December 1, 1993
Sex difference in the antidiuretic activity of vasopressin in the rat
Y X Wang, R M Edwards, P Nambi, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1994
Nonpeptide endothelin receptor antagonists. III. Effect of SB 209670 and BQ123 on acute renal failure in anesthetized dogs
D P Brooks, P D dePalma, M Gellai, et al.
The Journal of Biological Chemistry
|
May 6, 1994
Cloning and characterization of a novel endothelin receptor from Xenopus heart
C Kumar, V Mwangi, P Nuthulaganti, et al.
Biochemical Pharmacology
|
February 4, 1998
Activation of glomerular mesangial cells by hepatocyte growth factor through tyrosine kinase and protein kinase C
N J Laping, B A Olson, R E DeWolf, et al.
The Journal of Biological Chemistry
|
February 25, 1993
Molecular characterization and regulation of the human endothelin receptors
N A Elshourbagy, D R Korman, H L Wu, et al.
Journal of Cardiovascular Pharmacology
|
May 22, 1998
Pharmacologic characterization of the novel, orally available endothelin-A--selective antagonist SB 247083
S A Douglas, P Nambi, M Gellai, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 160) with videos related to
Sort By:
Page
of 16
Molecular and Cellular Biochemistry
|
February 9, 1994
Human AT1 receptor is a single copy gene: characterization in a stable cell line
N Aiyar, E Baker, H L Wu, et al.
British Journal of Pharmacology
|
April 11, 2007
GW3965, a synthetic liver X receptor (LXR) agonist, reduces angiotensin II-mediated pressor responses in Sprague-Dawley rats
C E Leik, N L Carson, J K Hennan, et al.
The American Journal of Pathology
|
July 6, 2000
Endothelin receptor subtype distribution predisposes coronary arteries to damage
C S Louden, P Nambi, M A Pullen, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 8, 1998
Nonpeptide endothelin receptor antagonists. XI. Pharmacological characterization of SB 234551, a high-affinity and selective nonpeptide ETA receptor antagonist
E H Ohlstein, P Nambi, D W Hay, et al.
The American Journal of Physiology
|
December 1, 1993
Sex difference in the antidiuretic activity of vasopressin in the rat
Y X Wang, R M Edwards, P Nambi, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1994
Nonpeptide endothelin receptor antagonists. III. Effect of SB 209670 and BQ123 on acute renal failure in anesthetized dogs
D P Brooks, P D dePalma, M Gellai, et al.
The Journal of Biological Chemistry
|
May 6, 1994
Cloning and characterization of a novel endothelin receptor from Xenopus heart
C Kumar, V Mwangi, P Nuthulaganti, et al.
Biochemical Pharmacology
|
February 4, 1998
Activation of glomerular mesangial cells by hepatocyte growth factor through tyrosine kinase and protein kinase C
N J Laping, B A Olson, R E DeWolf, et al.
The Journal of Biological Chemistry
|
February 25, 1993
Molecular characterization and regulation of the human endothelin receptors
N A Elshourbagy, D R Korman, H L Wu, et al.
Journal of Cardiovascular Pharmacology
|
May 22, 1998
Pharmacologic characterization of the novel, orally available endothelin-A--selective antagonist SB 247083
S A Douglas, P Nambi, M Gellai, et al.
Page
of 16